Trial intelligence / Profile preview

PRIME: NAC for Preventing Renal Injury After Cardiac Surgery

NCT00188630Phase 3Completed

Sponsor
University Health Network
Start
Jul 2003
Primary completion
Feb 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of acetylcysteine in acute kidney injury (AKI), sponsored by University Health Network. Started Jul 2003; status: completed.

02

Drugs

acetylcysteine
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT00188630.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00188630.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call